Yubo International Biotech Limited Share Price
Equities
YBGJ
US9883661004
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3487 USD | +39.54% | +66.05% | +16.23% |
Sales 2022 | 0.1 8.35 | Sales 2023 | 0.6 48.42 | Capitalization | 35.95M 2.88B |
---|---|---|---|---|---|
Net income 2022 | -1M -80.08M | Net income 2023 | -1M -80.08M | EV / Sales 2022 | 116,560,264 x |
Net Debt 2022 | 772K 61.85M | Net Debt 2023 | 386K 30.88M | EV / Sales 2023 | 60,084,725 x |
P/E ratio 2022 |
-9.36
x | P/E ratio 2023 |
-30.1
x | Employees | 18 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 6.63% |
1 day | +39.54% | ||
1 week | +66.05% | ||
Current month | -64.78% | ||
1 month | -64.78% | ||
3 months | -32.68% | ||
6 months | +64.33% | ||
Current year | +16.23% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Wang
CEO | Chief Executive Officer | 57 | 31/12/18 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 31/12/18 |
Wang Yang
BRD | Director/Board Member | 45 | 31/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wang Yang
BRD | Director/Board Member | 45 | 31/12/18 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 31/12/18 |
Zhi Hui Bai
BRD | Director/Board Member | 39 | 31/12/19 |
Date | Price | Change | Volume |
---|---|---|---|
30/04/24 | 0.3487 | +39.54% | 19,803 |
29/04/24 | 0.2499 | +19.00% | 36,800 |
Delayed Quote OTC Markets, April 30, 2024 at 03:51 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+16.23% | 29.94M | |
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |
- Stock Market
- Equities
- YBGJ Stock